Obesity and weight management (Medical management of overweight and obesity)

What is obesity and weight management?

Weight management is the medical care of overweight and obesity. It combines changes to diet and physical activity, support for behaviour change, and, for some people, medicines or surgery. The aim is to improve health and reduce the risks linked to excess weight, such as type 2 diabetes, high blood pressure, joint problems, and some cancers, rather than to chase a particular look.

Much of the recent attention is on GLP-1 medicines, such as semaglutide (Wegovy) and the dual-acting tirzepatide (Mounjaro). These injections reduce appetite and can lead to meaningful weight loss in many people, but they are not a quick fix or a miracle cure. They work alongside diet and activity changes, have side effects, and weight is often regained when they are stopped.

Obesity is a long-term condition driven by many factors, including biology, environment, and circumstances. It is not simply a matter of willpower. Effective management is usually ongoing and tailored, not a single course of treatment.

This guide explains the options honestly, including what medicines can and cannot do, who they may suit, the risks, and how to choose responsible care.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

GLP-1 medicines vs bariatric surgery (general picture)

This is a general comparison only. The right option depends on your health, your weight, and your preferences, and should be decided with a specialist.

Preparing for your treatment

• Be clear about your goal: weight management is about health, so discuss what improvement matters most to you.
• Bring a full list of your medicines and any health conditions, including diabetes, heart, gallbladder, or thyroid problems.
• Tell the clinician if you are pregnant, planning pregnancy, or breastfeeding, as GLP-1 medicines are not used in pregnancy.
• Mention any history of pancreatitis, gallstones, eating disorders, or significant mental health problems.
• Be ready to discuss your eating patterns, activity, sleep, and circumstances honestly.
• Ask how progress will be measured and reviewed, and what happens if a treatment is not working.
• If you might need an operation, an endoscopy, or sedation, tell the anaesthetist or team in advance that you take a GLP-1 or dual GIP/GLP-1 weight-loss medicine (such as semaglutide or tirzepatide), including any bought privately. These medicines slow the stomach, so food can remain even after the usual fasting time and could pass into the lungs during anaesthesia or deep sedation. There is no single fixed time to pause the medicine beforehand — do not stop it on your own; the team will assess you individually.
• Think about cost and sustainability if considering long-term medicine, since stopping often leads to weight regain.

What happens

A weight management appointment usually starts with a full assessment: your weight history, eating and activity patterns, other health conditions, medicines, and how excess weight is affecting you. Your height, weight (and BMI), blood pressure, and sometimes blood tests are checked.

The clinician explains the realistic options, from lifestyle support to medicines or, for some, surgery. If a GLP-1 medicine is appropriate, they explain how it is injected, the side effects, the dose build-up, and the plan for review. In NHS care, these medicines are prescribed through specialist weight management services for people who meet the criteria.

You agree a plan together, including lifestyle support, any medicine, how progress is measured, and when it will be reviewed. Medicines are usually continued only if they are helping, and are part of ongoing care rather than a single course.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

GLP-1 medicines are not without risks or a permanent fix. The most common problem is gut upset, which often eases but can be hard to tolerate; weight is frequently regained after stopping. Rarely, pancreatitis or gallbladder problems occur; severe, persistent tummy pain that spreads through to the back, usually with nausea or vomiting, needs urgent assessment, and the medicine should be stopped if pancreatitis is suspected and not restarted if it is confirmed. Buying these medicines online without proper assessment, monitoring, or support is unsafe. Discuss your full medical history, including pancreatitis, gallstones, eating disorders, and any plan for pregnancy.

Published figures to discuss

Weight loss varies widely between people, so averages from trials do not predict any one person's result. GLP-1 medicines produce substantial average weight loss in studies, but response ranges from large to minimal, and weight is commonly regained after stopping. Side-effect rates also vary. The figures below are cautious and drawn from trial and review data; your clinician will set realistic expectations for you.

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

Weight management is an ongoing process rather than something you recover from. What matters is steady progress, managing side effects, and regular review.

• Gut symptoms such as nausea early on, often settling with time
• Gradual rather than rapid weight change
• Feeling fuller sooner and eating less
• Needing dose increases over the first weeks
• Weight regain if medicine is stopped without a maintenance plan

Aftercare

• Take any medicine exactly as prescribed and build the dose up as advised to reduce side effects.
• Keep up the diet, activity, and behavioural changes, since medicines work best alongside them.
• Protect muscle with adequate protein and activity, as advised, during weight loss.
• Stay hydrated, especially if you have nausea, vomiting, or diarrhoea.
• Attend review appointments so progress, side effects, and health markers are checked.
• Know who to contact about side effects and what symptoms need urgent attention.
• Discuss a maintenance plan before stopping any medicine, to reduce weight regain.

• Clear instructions on how and when to inject, and how the dose increases
• A plan for managing nausea and other side effects
• Diet and activity support arranged alongside medicine
• Review appointments booked
• Contact details for side-effect and urgent queries
• An agreed plan for what happens if treatment is stopped

⚠ Get urgent help if…

• Severe, persistent tummy pain that often spreads through to your back, usually with feeling or being sick (possible pancreatitis) — stop the medicine and seek urgent medical help; it should not be restarted if pancreatitis is confirmed
• Sudden, painless loss of vision or part of your vision, or rapidly worsening eyesight — go straight to an eye casualty department or A&E (a very rare optic-nerve problem, NAION, has been linked to semaglutide)
• Persistent vomiting or diarrhoea with signs of dehydration
• Severe upper-right tummy pain, fever, or yellowing of the skin (possible gallbladder problem)
• Signs of a serious allergic reaction, such as swelling of the face or throat or difficulty breathing
• Symptoms of very low blood sugar if you also take diabetes medicines (shakiness, sweating, confusion)
• Low mood, or thoughts of harming yourself — seek help and tell your clinician
• Any new, severe, or unexpected symptom after starting treatment

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A realistic result from weight management is gradual, meaningful weight loss for many people, alongside improvements in health markers such as blood pressure and blood sugar. GLP-1 medicines plus lifestyle change produce substantial average weight loss in trials, but results vary widely between individuals and some people respond little.

Results are not guaranteed and are not necessarily permanent. Because appetite usually returns and weight is often regained after stopping medicine, weight management is best understood as ongoing care of a long-term condition rather than a one-off cure. Health gains, not a number on the scales alone, are the goal.

How long results last depends on whether changes are maintained and whether treatment continues. With GLP-1 medicines, much of the lost weight is commonly regained within about a year of stopping in trial settings, which is why long-term planning matters. Bariatric surgery tends to give more durable weight loss but needs lifelong follow-up. Your clinician will discuss how to sustain benefits over time.

Related tests, treatments or support

Weight management often goes alongside treatment of related conditions, such as type 2 diabetes, high blood pressure, sleep apnoea, and joint problems. Some GLP-1 medicines are also used to treat diabetes, so your clinician will coordinate care to avoid duplication. Dietitian, psychological, and activity support are commonly combined with any medicine.

Follow-up & long-term care

You should be reviewed at set points to check weight change, side effects, and health markers, and to decide whether to continue, adjust, or stop treatment. In NHS care, semaglutide is prescribed and reviewed through specialist weight-management services; in England, tirzepatide is being introduced through both specialist services and primary care, and arrangements differ across the UK nations. Make sure you know who is responsible for your follow-up and how to contact them about side effects.

• Continue lifestyle changes alongside any medicine, long term.
• Attend regular reviews of weight, side effects, and health markers.
• Maintain protein intake and activity to protect muscle during weight loss.
• Discuss a maintenance or alternative plan before stopping medicine.
• Keep related conditions, such as diabetes and blood pressure, under review.
• Tell your clinician about new medicines, pregnancy plans, or new symptoms.

Repeat, follow-on and what comes next

• Medicines are commonly adjusted, switched, or stopped depending on response and side effects.
• If one medicine is not tolerated or not working, another approach may be tried.
• Stopping treatment often leads to weight regain, so plans are reviewed rather than fixed.
• Bariatric surgery may rarely need revision and always needs lifelong follow-up.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

• A proper assessment before any medicine, with checks on history and pregnancy plans.
• Lifestyle, dietetic, and psychological support alongside treatment.
• Regular review of weight, side effects, and health markers.
• A named contact for side effects and clear advice on urgent symptoms.
• An agreed plan for maintenance or alternatives when treatment stops.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

• Whether care is medicine-based, lifestyle support, or surgery
• The specific medicine and the dose reached, since GLP-1 medicines are usually long-term
• Frequency of appointments and monitoring blood tests
• Dietitian, psychological, and activity support included in the programme
• Whether bariatric surgery and its lifelong follow-up are involved
• Ongoing cost over months or years, not just an initial prescription

• The consultation and assessment fee and what it includes
• The cost of the medicine and how long it is likely to be needed
• Which monitoring and review appointments are included
• Whether dietitian and psychological support are part of the package
• What happens, and what it costs, if the treatment is not working
• What support is provided if you stop the medicine
• Cancellation policy and how care is coordinated with your GP

On the NHS? Lifestyle support and, for those who meet the criteria, GLP-1 medicines and bariatric surgery are available on the NHS or HSC. What is funded depends on the medicine, your clinical eligibility, which UK nation you live in, and the local commissioned pathway. NICE technology appraisals set routine entitlement in England and Wales; Scotland follows Scottish Medicines Consortium (SMC) and NHS Scotland pathways; Northern Ireland uses HSC commissioning arrangements. Availability through specialist and primary-care services therefore varies, so check the current national and local pathway rather than assuming an English rule applies. England (position as at 2026, subject to review): semaglutide (Wegovy) is normally prescribed through a specialist weight-management service, and tirzepatide (Mounjaro) is being introduced in phases through both specialist services and primary care, initially for those with the highest clinical need. Many people use private care, but assessment and monitoring remain important.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Consent traps and marketing red flags

These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.

Choosing a specialist safely

• Check the specialist is on the GMC Specialist Register for this area.
• Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
• You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
• Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
• You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Take this to your consultation. A good specialist will welcome every one of these.

• What does successful treatment look like for my health, not just my weight?
• Which option suits me best, and what are its realistic benefits and downsides?
• What side effects should I expect, and what would make me stop the medicine?
• What is the plan if the treatment does not work, or when I stop it?
• How will my progress and safety be monitored, and by whom?
• How does this fit with my other conditions and medicines, such as diabetes?
• Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
• Will you be the specialist who carries out my treatment, and who looks after me afterwards?
• What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
• What does a realistic result look like — and what can this treatment not achieve?
• What are my options, including waiting, doing nothing for now, or choosing a different approach?
• Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
• What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Find a verified specialist for obesity and weight management

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: NICE NG246 — Overweight and obesity management NICE TA875 — Semaglutide for managing overweight and obesity NICE TA1026 — Tirzepatide for managing overweight and obesity NHS England — Medicines for obesity (weight management injections) NHS — Tirzepatide medicine information Weight change after stopping semaglutide/tirzepatide (PMC) MHRA — GLP-1 medicines for weight loss and diabetes: what you need to know Mounjaro (tirzepatide) UK SmPC — electronic medicines compendium Wegovy (semaglutide) UK SmPC — electronic medicines compendium MHRA — GLP-1/GIP agonists: strengthened acute pancreatitis warnings MHRA — Semaglutide: risk of NAION (optic-nerve eye problem) MHRA — GLP-1/GIP agonists: pulmonary aspiration risk during anaesthesia/sedation NHS inform (Scotland) — Diabetes and weight-loss medication NHS Wales (BCUHB) — Weight-loss medications Northern Ireland Formulary — Obesity (patient area)

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.